Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03161756
Title Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma (CHARLI)
Acronym CHARLI
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Melanoma and Skin Cancer Trials Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Border Medical Oncology Research Unit Albury New South Wales 2640 Australia Details
Bendigo Health Bendigo New South Wales 3550 Australia Details
Calvary Mater Newcastle Waratah New South Wales 2298 Australia Details
Royal Brisbane and Women's Hospital Herston Queensland 4029 Australia Details
Royal Hobart Hospital Hobart Tasmania 7000 Australia Details
Box Hill Hospital Box Hill Victoria 3128 Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Health Melbourne Victoria 3004 Australia Details
Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field